Почетна › Рак на бели дробови со не-мали клетки › Калифорнија › San Diego
Клинички испитувања за Рак на бели дробови со не-мали клетки во San Diego, CA
48 студии за Рак на бели дробови со не-мали клетки бараат учесници на локации во и околу San Diego (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Се регрутираФаза 2/3
- UC San Diego Health - Moores Cancer Center /ID# 278836, La Jolla · на 11 милји
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Се регрутираФаза 3
- Kaiser Permanente-San Diego Zion, San Diego
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Се регрутираФаза 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · на 11 милји
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Се регрутираФаза 1/2
- University of San Diego Moores Cancer Center, La Jolla · на 11 милји
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Се регрутираФаза 3
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Се регрутираФаза 1
- University of California San Diego Moores Cancer Center, San Diego
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Се регрутираФаза 1
- ALX Center 9, La Jolla · на 11 милји
A Study of PHN-012 in Patients With Advanced Solid Tumors
Се регрутираФаза 1
- PHN-012-001 Site, San Diego
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Се регрутираФаза 2
- University of California at San Diego, La Jolla · на 11 милји
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Се регрутираФаза 3
- UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
- UC San Diego Medical Center - Hillcrest, San Diego
- UCSD Medical Center - Rancho Bernardo, San Diego
- и уште 3
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Се регрутираНабљудувачка студија
- University of California San Diego, La Jolla · на 11 милји
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- Moores Cancer Center at UC San Diego Health, La Jolla · на 11 милји
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- University of California San Diego Health, La Jolla · на 11 милји
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Се регрутираФаза 1/2
- Scripps Clinic Torrey Pines (Scripps Cancer Center), La Jolla · на 11 милји
- Scripps Green Hospital, La Jolla · на 11 милји
- Scripps Shiley Pavilion, La Jolla · на 11 милји
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Се регрутираФаза 3
- Kaiser Permanente San Diego Mission Road, San Diego
Pan-tumor MRD Study
Се регрутираНабљудувачка студија
- Medical Oncology Associates of San Diego (MOASD), San Diego
- Medical Oncology Associates of San Diego, San Diego
Intratumoral N17350 in Advanced Solid Tumors
Се регрутираФаза 1/2
- Scripps Clinic Torrey Pines - La Jolla, San Diego
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Се регрутираФаза 2/3
- University Of California - San Diego Moores Cancer Center, La Jolla · на 11 милји
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Се регрутираФаза 3
- Clinical Study Site, San Diego
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Се регрутираНабљудувачка студија
- University of California, San Diego, La Jolla · на 11 милји
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Се регрутираФаза 1
- UCSD Moores Cancer Center, La Jolla · на 11 милји
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Се регрутираФаза 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · на 11 милји
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Се регрутираФаза 3
- Research Site, San Diego
- Research Site, La Jolla · на 11 милји
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Се регрутираФаза 1
- University of California - San Diego Moores Cancer Center, La Jolla · на 11 милји
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Се регрутираФаза 3
- Sharp Memorial Hospital ( Site 9544), San Diego
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Се регрутираФаза 1
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Се регрутираФаза 1
- University of California San Diego, Moores Cancer Center, San Diego
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Се регрутираФаза 3
- Research Site, San Diego
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Се регрутираФаза 2
- Kaiser Permanente San Diego Mission Road, San Diego
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Се регрутираФаза 3
- UC San Diego Medical Center - Hillcrest, San Diego
- California Protons Cancer Therapy Center, San Diego
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Се регрутираФаза 1/2
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Се регрутираФаза 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Се регрутираФаза 1/2
- University of California, San Diego Moores Cancer Center, San Diego
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Се регрутираФаза 1/2
- UCSD Moores Cancer Center, La Jolla · на 11 милји
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Се регрутираФаза 2
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Се регрутираФаза 1
- University of California San Diego Moores Cancer Center, San Diego
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Се регрутираФаза 3
- Research Site, San Diego
- Research Site, La Jolla · на 11 милји
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2/3
- Kaiser Permanente-San Diego Zion, San Diego
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Се регрутираФаза 2
- University of California San Diego Moores Cancer Center, La Jolla · на 11 милји
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Се регрутираФаза 1/2
- University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center, La Jolla · на 11 милји
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
Се регрутираФаза 1/2
- Research Site, La Jolla · на 11 милји
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
Се регрутираФаза 1/2
- VA San Diego Healthcare System, San Diego, CA, San Diego
Retifanlimab and Ruxolitinib In Solid Malignancies
Се регрутираФаза 1/2
- University of California, San Diego Moores Cancer Center, La Jolla · на 11 милји
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Се регрутираНабљудувачка студија
- Massive Bio SYNERGY-AI site, La Jolla · на 11 милји
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Се регрутираФаза 1/2
- UCSD Moores Cancer Center, La Jolla · на 11 милји
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Се регрутираФаза 1
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
Испитувања за Рак на бели дробови со не-мали клетки во други градови
- Houston, TX145 студии
- New York City, NY121 студија
- Arlington, VA104 студии
- Nashville, TN97 студии
- Boston, MA90 студии
- Los Angeles, CA87 студии
- St. Louis, MO73 студии
- Chicago, IL61 студија
- Baltimore, MD60 студии
- San Antonio, TX59 студии
- Columbus, OH57 студии
- Washington, DC55 студии
Други студии во San Diego
- Рак на дојка41 студија
- Рак (сите типови)32 студии
- Рак на простата31 студија
- Метастатски карцином30 студии
- Колоректален карцином25 студии
- Карцином на јајниците24 студии
- Карцином на панкреасот24 студии
- Рак на бели дробови23 студии
- Дебелина23 студии
- Срцева слабост23 студии
- Депресија21 студија
- Меланом18 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.